Showing results (11-20 of 215) with videos related to
Sort By:
Pageof 22
Open Forum Infectious Diseases|May 1, 2025
Serosurveillance to Support HPV Vaccination in EnglandKavita Panwar, Kazutomo Yokoya, Marta Checchi, et al.The Journal of Infectious Diseases|June 20, 2018
The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016David Mesher, Kavita Panwar, Sara L Thomas, et al.Lancet (London, England)|November 6, 2021
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational studyMilena Falcaro, Alejandra Castañon, Busani Ndlela, et al.Plos One|March 10, 2016
HPV Serology Testing Confirms High HPV Immunisation Coverage in EnglandDavid Mesher, Elaine Stanford, Joanne White, et al.Sexually Transmitted Infections|February 7, 2019
Epidemiology of genital warts in the British population: implications for HPV vaccination programmesPam Sonnenberg, Clare Tanton, David Mesher, et al.Sexually Transmitted Infections|December 28, 2020
HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in LondonEleanor M King, David Mesher, Pam Sonnenberg, et al.Papillomavirus Research (Amsterdam, Netherlands)|June 20, 2017
Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine typesClare Tanton, David Mesher, Simon Beddows, et al.Journal of Clinical Pathology|November 21, 2014
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisationDavid Mesher, Kate Cuschieri, Sam Hibbitts, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2025
Developing, validating and testing non-vaccine-preventable human papillomavirus to control for differences in sexual behaviour when evaluating HPV vaccinationEmily Dema, Jaimie Z Shing, Marta Checchi, et al.International Journal of STD & AIDS|August 20, 2024
Factors associated with human papillomavirus, hepatitis A, hepatitis B and mpox vaccination uptake among gay, bisexual and other men who have sex with men in the UK- findings from the large community-based RiiSH-Mpox surveyGeorge Baldry, Dawn Phillips, Ruth Wilkie, et al.Pageof 22